UV-synthesized albumin-based doxorubicin nanoparticles induce apoptosis and modulate leukemia surface markers while overcoming drug resistance.


Danışman-Kalındemirtaş F., Sert E., Kariper I. A., Korkut I. N., Erdem-Kuruca S.

Naunyn-Schmiedeberg's archives of pharmacology, 2025 (SCI-Expanded, Scopus) identifier